PATENT CLAIM ANALYSIS

Application Number: 15958346
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "252130"]

Abstract:
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. Formulations for increased solubility are disclosed. Combination therapy with antibodies and PK/PD data are also disclosed.

Claim (Index 60):
The method of  claim 55 , wherein the administering is topical.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 91.0
- Lexical Diversity: 1.51515
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13999670', '15355910', '13724396', '14657276', '15016599']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7361460466864332
- 35 USC 102 Novelty (BERT): 0.5199171768669367
- Combined Prediction Score: 0.7145231597044835
- Mean Citation Score: 226.673914
- Max Citation Score: 281.58234
- Similarity Product: 172.66154362225768

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test